Synthesis and antitumor properties of derivatives 4-substituted-5-(piridin-4-yl)-4h-1,2,4-triazole-3-thiol
Close
Articolul precedent
Articolul urmator
686 5
Ultima descărcare din IBN:
2023-05-29 14:19
SM ISO690:2012
RUSNAC, Roman, ZATIC, Ana, PAHOLNITSCAIA, Anastasia, BARBA, Nicanor, PERREAULT, M., GULYA, Aurelian. Synthesis and antitumor properties of derivatives 4-substituted-5-(piridin-4-yl)-4h-1,2,4-triazole-3-thiol. In: Physical Methods in Coordination and Supramolecular Chemistry, 8-9 octombrie 2015, Chişinău. Chisinau, Republic of Moldova: 2015, XVIII, p. 131.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Physical Methods in Coordination and Supramolecular Chemistry
XVIII, 2015
Conferința ""Physical Methods in Coordination and Supramolecular Chemistry""
Chişinău, Moldova, 8-9 octombrie 2015

Synthesis and antitumor properties of derivatives 4-substituted-5-(piridin-4-yl)-4h-1,2,4-triazole-3-thiol


Pag. 131-131

Rusnac Roman1, Zatic Ana1, Paholnitscaia Anastasia1, Barba Nicanor1, Perreault M.2, Gulya Aurelian1
 
1 Moldova State University,
2 CHUL Research Center (Université Laval)
 
Teze de doctorat:
 
Disponibil în IBN: 22 aprilie 2020


Rezumat

In recent years, the chemistry of triazoles and their fused heterocyclic derivatives has received considerable attention owing to their synthetic and effective biological importance [1]. Literature survey reveals that 1,2,4-triazole derivatives exhibit a wide range of biological activities including Antibacterial, Antifungal, Antitumour, Anti-inflammatory, Antitubercular, Hypoglycemic, Antidepressant, Anticonvulsant, Anticancer, Antimalarial, Antiviral, Antiproliferative, Analgesic and Antimigraine [1,2]. The derivatives of 4-substituted-5(piridin-4-yl)-4H-1,2,4-triazole-3-thiol were synthesized according to scheme:schemeTable. The antiproliferative activity of 4-substituted-5-(piridin-4-yl)-4H-1,2,4-triazole-3-thiol on human on leukemia (HL-60) cells.tableThe obtained data demonstate that the synthesized compounds show moderate (3-11%) antiproliferative activity. Compounds e and d were tested on melanoma (MeW-164) and on human leukemia (HL-60) cells, in the range of (0,1-10 μM) concentrations. The results proved thait they have a higher (16-23%) antiproliferative activity. 

Crossref XML Export

<?xml version='1.0' encoding='utf-8'?>
<doi_batch version='4.3.7' xmlns='http://www.crossref.org/schema/4.3.7' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.crossref.org/schema/4.3.7 http://www.crossref.org/schema/deposit/crossref4.3.7.xsd'>
<head>
<doi_batch_id>ibn-101897</doi_batch_id>
<timestamp>1713545615</timestamp>
<depositor>
<depositor_name>Information Society Development Instiute, Republic of Moldova</depositor_name>
<email_address>idsi@asm.md</email_address>
</depositor>
</head>
<body>
<collection>
<collection_metadata>
<full_title>Physical Methods in Coordination and Supramolecular Chemistry</full_title>
</collection_metadata>
<collection_issue>
<publication_date media_type='print'>
<year>2015</year>
</publication_date>
</collection_issue>
<collection_article publication_type='full_text'><titles>
<title>Synthesis and antitumor properties of derivatives 4-substituted-5-(piridin-4-yl)-4h-1,2,4-triazole-3-thiol</title>
</titles>
<contributors>
<person_name sequence='first' contributor_role='author'>
<given_name>Roman</given_name>
<surname>Rusnac</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>Ana</given_name>
<surname>Zatic</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>Anastasia</given_name>
<surname>Paholniţcaia</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>Nicanor</given_name>
<surname>Barbă</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>M.</given_name>
<surname>Perreault</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>Aurelian</given_name>
<surname>Gulea</surname>
</person_name>
</contributors>
<publication_date media_type='print'>
<year>2015</year>
</publication_date>
<pages>
<first_page>131</first_page>
<last_page>131</last_page>
</pages>
</collection_article>
</collection>
</body>
</doi_batch>